“Hurts less, lasts longer” experiences of young people receiving high-dose subcutaneous infusions of benzathine penicillin G to prevent rheumatic heart disease
Julie Cooper, Stephanie L Enkel, Dhevindri Moodley, Hazel Dobinson, Erik Andersen, Joseph H Kado, Renae K Barr, Sam Salman, Michael G Baker, Jonathan R Carapetis, Laurens Manning, Anneka Anderson, View ORCID ProfileJulie Bennett
doi: https://doi.org/10.1101/2023.09.13.23295467
Julie Cooper
1Department of Public Health, University of Otago, Wellington, New Zealand
Stephanie L Enkel
2Telethon Kids Institute, Nedlands, Western Australia
Dhevindri Moodley
1Department of Public Health, University of Otago, Wellington, New Zealand
Hazel Dobinson
3Te Whatu Ora, Capital, Coast and Hutt Valley, Wellington, New Zealand
Erik Andersen
3Te Whatu Ora, Capital, Coast and Hutt Valley, Wellington, New Zealand
Joseph H Kado
2Telethon Kids Institute, Nedlands, Western Australia
Renae K Barr
2Telethon Kids Institute, Nedlands, Western Australia
Sam Salman
2Telethon Kids Institute, Nedlands, Western Australia
4Clinical Pharmacology and Toxicology Unit, PathWest, Perth, Western Australia
5Internal Medicine, the University of Western Australia, Australia
Michael G Baker
1Department of Public Health, University of Otago, Wellington, New Zealand
Jonathan R Carapetis
2Telethon Kids Institute, Nedlands, Western Australia
6Perth Children’s Hospital, Nedlands, Western Australia
7Centre for Child Health Research, the University of Western Australia, Australia
Laurens Manning
2Telethon Kids Institute, Nedlands, Western Australia
5Internal Medicine, the University of Western Australia, Australia
8Fiona Stanley Hospital, Nedlands, Western Australia
Anneka Anderson
9Faculty of Medical and Health Sciences, Te Kupenga Hauora Māori, University of Auckland, Auckland, New Zealand
Julie Bennett
1Department of Public Health, University of Otago, Wellington, New Zealand
Article usage
Posted September 14, 2023.
“Hurts less, lasts longer” experiences of young people receiving high-dose subcutaneous infusions of benzathine penicillin G to prevent rheumatic heart disease
Julie Cooper, Stephanie L Enkel, Dhevindri Moodley, Hazel Dobinson, Erik Andersen, Joseph H Kado, Renae K Barr, Sam Salman, Michael G Baker, Jonathan R Carapetis, Laurens Manning, Anneka Anderson, Julie Bennett
medRxiv 2023.09.13.23295467; doi: https://doi.org/10.1101/2023.09.13.23295467
“Hurts less, lasts longer” experiences of young people receiving high-dose subcutaneous infusions of benzathine penicillin G to prevent rheumatic heart disease
Julie Cooper, Stephanie L Enkel, Dhevindri Moodley, Hazel Dobinson, Erik Andersen, Joseph H Kado, Renae K Barr, Sam Salman, Michael G Baker, Jonathan R Carapetis, Laurens Manning, Anneka Anderson, Julie Bennett
medRxiv 2023.09.13.23295467; doi: https://doi.org/10.1101/2023.09.13.23295467
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (200)
- Cardiovascular Medicine (2915)
- Dermatology (249)
- Emergency Medicine (438)
- Epidemiology (12707)
- Forensic Medicine (12)
- Gastroenterology (826)
- Genetic and Genomic Medicine (4565)
- Geriatric Medicine (414)
- Health Economics (726)
- Health Informatics (2912)
- Health Policy (1068)
- Hematology (385)
- HIV/AIDS (921)
- Medical Education (422)
- Medical Ethics (115)
- Nephrology (466)
- Neurology (4329)
- Nursing (234)
- Nutrition (636)
- Oncology (2261)
- Ophthalmology (643)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (278)
- Palliative Medicine (83)
- Pathology (497)
- Pediatrics (1196)
- Primary Care Research (494)
- Public and Global Health (6913)
- Radiology and Imaging (1524)
- Respiratory Medicine (915)
- Rheumatology (436)
- Sports Medicine (382)
- Surgery (484)
- Toxicology (60)
- Transplantation (210)
- Urology (178)